A novel vaccine with beta₂-microglobulin linked to a viral epitope stimulates a CTL response and provides immunity to the virus

dc.contributor.advisorKitto, George B.en
dc.creatorPiper, John Danielen
dc.date.accessioned2008-08-28T21:37:21Zen
dc.date.available2008-08-28T21:37:21Zen
dc.date.issued2003en
dc.description.abstractDesigning a vaccine that can elicit a strong cytotoxic T-lymphocytes (CTL) response will be an important component of vaccines against many viruses, but in particular against HIV. CTL stimulation occurs through the recognition of epitopes presented in the context of the class-I major histocompatibility complex (MHC-I). As a way to achieve this, the physical coupling of a viral epitope to the N-terminus of β2-microglobulin (β2m) via a flexible linker has been explored. With the stimulation of CTLs against the Sendai virus as a model, both the effect of linker size on the vaccine and the ability of the β2m-viral epitope fusion vaccine to trigger a primary immune response, as either a recombinant protein expressed in E. coli or as part of a mammalian expression vector are presented in this work. Here we show that as a DNA vaccine, β2mlinked to the immunodominant Sendai NP(324-332) epitope, administered intramuscularly (IM) with or without a plasmid encoding for the cytokine IL-12, can cause the proliferation of viral specific splenocytes. However, when the vaccine was administered IM or subcutaneously as recombinant protein, no response was observed. We also show that a construct with a 21 amino acid (AA) linker stimulates more viral specific splenocytes than constructs with either a 10 AA or a 15 AA linker. Further, DNA vaccine dosages of 100 µg and 200 µg generate more viral specific splenocytes than dosages of 400 µg or 800 µg. We suggest that the reason for this might be high-localized concentrations of β2m. Finally, we show that in response to a sub-lethal challenge with the Sendai virus, mice primed with both the β2m-Sendai epitope DNA vaccine and the IL-12 plasmid can trigger the early arrival of viral specific CD8+ memory cells in the lungs.
dc.description.departmentChemistry and Biochemistryen
dc.description.departmentBiochemistryen
dc.format.mediumelectronicen
dc.identifierb57186017en
dc.identifier.oclc56889717en
dc.identifier.proqst3118058en
dc.identifier.urihttp://hdl.handle.net/2152/862en
dc.language.isoengen
dc.rightsCopyright is held by the author. Presentation of this material on the Libraries' web site by University Libraries, The University of Texas at Austin was made possible under a limited license grant from the author who has retained all copyrights in the works.en
dc.subject.lcshAIDS vaccinesen
dc.subject.lcshHIV (Viruses)en
dc.subject.lcshImmunoglobulinsen
dc.titleA novel vaccine with beta₂-microglobulin linked to a viral epitope stimulates a CTL response and provides immunity to the virusen
dc.type.genreThesisen
thesis.degree.departmentBiochemistryen
thesis.degree.disciplineBiochemistryen
thesis.degree.grantorThe University of Texas at Austinen
thesis.degree.levelDoctoralen
thesis.degree.nameDoctor of Philosophyen

Access full-text files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
piperjd036.pdf
Size:
5.05 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.65 KB
Format:
Plain Text
Description: